SAPHNELO (anifrolumab-fnia) Buy-and-Bill Reference Guide
June 17, 2024
The Buy-and-Bill Reference Guide is a resource tool for HCP offices provided for educational purposes only. Additionally, the AstraZeneca Access 360™ program provides personal support to connect patients to affordability programs and streamline access and reimbursement processes for providers.
To view the Buy-and-Bill Reference Guide, click here!
The information provided is for educational purposes only and is not intended to serve as guidance for specific coding, billing, and claims submissions. The decision on which codes best describe the services provided must be made by the individual providers based on specific payer guidance and requirements. The use of this information does not guarantee payment or that any payment received will cover your costs.
For US Healthcare Professionals
SAPHNELO is a registered trademark and AstraZeneca Access 360 is a trademark of the AstraZeneca group of companies.
©2024 AstraZeneca. All rights reserved. US-87769 Last Updated 4/24